Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Impax Buys Generic Drugs from Teva and Allergan for $586 Million
Impax Laboratories IPXL -3.
Flu nose spray doesn’t work for children; use shots instead, federal expert panel says
The nasal spray version of the annual flu vaccine failed to protect children last year for the third year in a row and should not be used this coming flu season, federal experts say.
Experimental Zika vaccine approved for human trials
The Food and Drug Administration approved an experimental Zika vaccine called GLS-5700 for a clinical trial in humans earlier today, the first such treatment to get an official nod from the agency.
FDA Approves Opko's NDA for Rayaldee
Opko Health announced that the U.
Understanding how chemical changes in the brain affect Alzheimer's disease
A new study from Western University is helping to explain why the long-term use of common anticholinergic drugs used to treat conditions like allergies and overactive bladder lead to an increased risk...
Microbial mass extinctions were kicked off by human evolution
It’s not just elephants and tigers we’re driving extinct – we’ve been drastically wiping out far tinier organisms too.
Vitamin D may not be the great solution to health problems
(Edmonton) As Canadians prepare for long summer days in the sun, a new publication is shedding light on the suggested medical benefits of a nutrient that comes with the sun's rays.
ARIAD Initiates Submission of New Drug Application for Brigatinib to the U.S. Food and Drug Administration Ahead of Plan
CAMBRIDGE, Mass.
India's pharma exports may reach $20 bn by 2020: Study
Delay in regulatory approvals may reduce pharma exports' growth by half.
Congo declares yellow fever epidemic
DR Congo on Monday declared a yellow fever outbreak in the capital Kinshasa, home to more than ten million people, and in two other western provinces.
Biogen targets Cambridge plant, up to 285 jobs at risk
Biogen ($BIIB) will sell or close a manufacturing plant at its headquarters in Cambridge, MA, shedding up to 285 jobs, moving the work there to a more efficient plants in its network.
Bristol's Opdivo-Yervoy melanoma combo wins speedy thumbs up from NICE
It was only yesterday that England’s cost watchdogs shot down a melanoma combination from Roche.
617
618
619
620
621
622
623
624
625